<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">40415771</PMID><DateRevised><Year>2025</Year><Month>05</Month><Day>27</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2604-7276</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Season>Jul-Sep</Season></PubDate></JournalIssue><Title>REC, interventional cardiology</Title><ISOAbbreviation>REC Interv Cardiol</ISOAbbreviation></Journal><ArticleTitle>[Left ventricular remodeling following transcatheter versus surgical aortic valve replacement: a speckle tracking study].</ArticleTitle><Pagination><StartPage>191</StartPage><EndPage>200</EndPage><MedlinePgn>191-200</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.24875/RECIC.M24000470</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND OBJECTIVES:">Transcatheter aortic valve implantation (TAVI) has emerged as an alternative and less invasive treatment to surgical aortic valve replacement (SAVR). Left ventricular global longitudinal strain (LV-GLS) can reveal changes in left ventricular performance before involvement of ejection fraction. Our aim was to present and evaluate our center&#x2019;s experience regarding short- and long-term reverse left ventricular remodeling using two-dimensional-speckle tracking echocardiography-derived LV-GLS after TAVI compared with SAVR.</AbstractText><AbstractText Label="METHODS:">Our multidisciplinary cardiac team carefully evaluated 65 patients for SAVR who presented with severe symptomatic aortic stenosis and who had high, intermediate, or low surgical risk. The patients underwent either TAVI with an Evolut-R self-expanding valve or SAVR. Echocardiographic evaluation was performed before, 1 month, and 1 year after the procedure.</AbstractText><AbstractText Label="RESULTS:">TAVI was performed in 31 patients and SAVR in 34 patients. The incidence of valvular and paravalvular leak was higher in the TAVI group despite early favorable LV remodeling with a significant decrease in left ventricular mass index and E/e&#x2019; shortly after the procedure and an early detectable improvement in LV-GLS from &#x2212;8.18 &#xb1; 1.81 to &#x2212;14.52 &#xb1; 2.52, reaching &#x2212;16.12 &#xb1; 2.69 at 1 year (<i>P</i> &lt; .001). This early improvement was not observed in the SAVR group. TAVI preserved right ventricular function without affecting tricuspid annular plane systolic excursion or increasing estimated pulmonary artery pressure.</AbstractText><AbstractText Label="CONCLUSIONS:">Patients who underwent TAVI had earlier and significantly better LV remodeling with early reduction in left ventricular mass index, E/e&#x2019; ratio, and significant early improvement in LV-GLS without concomitant impairment of left ventricular ejection fraction percentage or deterioration of right ventricular function.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Sociedad Espa&#xf1;ola de Cardiolog&#xed;a.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El-Saied</LastName><ForeName>Shaimaa B</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Faculty of Medicine, Tanta University, Tanta, Egipto Cardiovascular Department Faculty of Medicine Tanta University Tanta Egipto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Atlm</LastName><ForeName>Ramy</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Faculty of Medicine, Tanta University, Tanta, Egipto Cardiovascular Department Faculty of Medicine Tanta University Tanta Egipto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghoneim</LastName><ForeName>Ahmed</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Faculty of Medicine, Tanta University, Tanta, Egipto Cardiothoracic Surgery Department Faculty of Medicine Tanta University Tanta Egipto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sherif</LastName><ForeName>Mohammed H</ForeName><Initials>MH</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Faculty of Medicine, Tanta University, Tanta, Egipto Cardiovascular Department Faculty of Medicine Tanta University Tanta Egipto.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Elbarbary</LastName><ForeName>Mohammed</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiovascular Department, Faculty of Medicine, Tanta University, Tanta, Egipto Cardiovascular Department Faculty of Medicine Tanta University Tanta Egipto.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Remodelado del ventr&#xed;culo izquierdo tras implante percut&#xe1;neo o sustituci&#xf3;n quir&#xfa;rgica de v&#xe1;lvula a&#xf3;rtica: estudio mediante <i>speckle tracking</i>.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>REC Interv Cardiol</MedlineTA><NlmUniqueID>9919033203206676</NlmUniqueID><ISSNLinking>2604-7306</ISSNLinking></MedlineJournalInfo><OtherAbstract Type="Publisher" Language="eng"><AbstractText Label="INTRODUCTION AND OBJECTIVES" NlmCategory="UNASSIGNED">Transcatheter aortic valve implantation (TAVI) has emerged as an alternative and less invasive treatment to surgical aortic valve replacement (SAVR). Left ventricular global longitudinal strain (LV-GLS) can reveal changes in left ventricular performance before involvement of ejection fraction. Our aim was to present and evaluate our center's experience regarding short- and long-term reverse left ventricular remodeling using two-dimensional-speckle tracking echocardiography-derived LV-GLS after TAVI compared with SAVR.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Our multidisciplinary cardiac team carefully evaluated 65 patients for SAVR who presented with severe symptomatic aortic stenosis and who had high, intermediate, or low surgical risk. The patients underwent either TAVI with an Evolut-R self-expanding valve or SAVR. Echocardiographic evaluation was performed before, 1 month, and 1 year after the procedure.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">TAVI was performed in 31 patients and SAVR in 34 patients. The incidence of valvular and paravalvular leak was higher in the TAVI group despite early favorable LV remodeling with a significant decrease in left ventricular mass index and E/e' shortly after the procedure and an early detectable improvement in LV-GLS from -8.18 &#xb1; 1.81 to -14.52 &#xb1; 2.52, reaching -16.12 &#xb1; 2.69 at 1 year (<i>P</i> &lt; .001). This early improvement was not observed in the SAVR group. TAVI preserved right ventricular function without affecting tricuspid annular plane systolic excursion or increasing estimated pulmonary artery pressure.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Patients who underwent TAVI had earlier and significantly better LV remodeling with early reduction in left ventricular mass index, E/e' ratio, and significant early improvement in LV-GLS without concomitant impairment of left ventricular ejection fraction percentage or deterioration of right ventricular function.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2024 Sociedad Espa&#xf1;ola de Cardiolog&#xed;a.</CopyrightInformation></OtherAbstract><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Left ventricular remodeling</Keyword><Keyword MajorTopicYN="N">SAVR</Keyword><Keyword MajorTopicYN="N">Surgical aortic valve replacement</Keyword><Keyword MajorTopicYN="N">TAVI</Keyword><Keyword MajorTopicYN="N">Transcatheter aortic valve implantation</Keyword><Keyword MajorTopicYN="N">Two-dimensional speckle tracking</Keyword></KeywordList><CoiStatement>CONFLICTO DE INTERESES: Ninguno.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>28</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>6</Hour><Minute>27</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>5</Month><Day>26</Day><Hour>5</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40415771</ArticleId><ArticleId IdType="pmc">PMC12097341</ArticleId><ArticleId IdType="doi">10.24875/RECIC.M24000470</ArticleId><ArticleId IdType="pii">2604-7306-recic-6-3-191</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thaden JJ, Nkomo VT, Enriquez-Sarano M. The global burden of aortic stenosis. <i>Prog Cardiovasc Dis.</i> 2014;56:565-571.</Citation><ArticleIdList><ArticleId IdType="pubmed">24838132</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaden JJ, Nkomo VT, Enriquez-Sarano M. The global burden of aortic stenosis. Prog Cardiovasc Dis. 2014;56:565&#x2013;571.</Citation><ArticleIdList><ArticleId IdType="pubmed">24838132</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. <i>N Engl J Med.</i> 2016;374:1609-1620.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040324</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040324</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. <i>N Engl J Med.</i> 2012;366:1686-1695.</Citation><ArticleIdList><ArticleId IdType="pubmed">22443479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodali SK, Williams MR, Smith CR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366:1686&#x2013;1695.</Citation><ArticleIdList><ArticleId IdType="pubmed">22443479</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. <i>N Engl J Med.</i> 2016;374:1609-1620.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040324</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack MJ, et al. Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients. N Engl J Med. 2016;374:1609&#x2013;1620.</Citation><ArticleIdList><ArticleId IdType="pubmed">27040324</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenaweser P, Stortecky S, Schwander S, et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. <i>Eur Heart J.</i> 2013;34:1894-1905.</Citation><ArticleIdList><ArticleId IdType="pubmed">23487519</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenaweser P, Stortecky S, Schwander S, et al. Clinical outcomes of patients with estimated low or intermediate surgical risk undergoing transcatheter aortic valve implantation. Eur Heart J. 2013;34:1894&#x2013;1905.</Citation><ArticleIdList><ArticleId IdType="pubmed">23487519</ArticleId></ArticleIdList></Reference><Reference><Citation>Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. <i>N Engl J Med.</i> 2019;380:1706-1715.</Citation><ArticleIdList><ArticleId IdType="pubmed">30883053</ArticleId></ArticleIdList></Reference><Reference><Citation>Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706&#x2013;1715.</Citation><ArticleIdList><ArticleId IdType="pubmed">30883053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. <i>N Engl J Med</i>. 2019;380:1695-1705.</Citation><ArticleIdList><ArticleId IdType="pubmed">30883058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695&#x2013;1705.</Citation><ArticleIdList><ArticleId IdType="pubmed">30883058</ArticleId></ArticleIdList></Reference><Reference><Citation>Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart:structural deterioration and compensatory mechanisms. <i>Circulation.</i> 2003;107:984-991.</Citation><ArticleIdList><ArticleId IdType="pubmed">12600911</ArticleId></ArticleIdList></Reference><Reference><Citation>Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart:structural deterioration and compensatory mechanisms. Circulation. 2003;107:984&#x2013;991.</Citation><ArticleIdList><ArticleId IdType="pubmed">12600911</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. <i>Circulation.</i> 2017;135:e1159-e1195.</Citation><ArticleIdList><ArticleId IdType="pubmed">28298458</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease:a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2017;135:e1159.</Citation><ArticleIdList><ArticleId IdType="pubmed">28298458</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain:a novel index of left ventricular systolic function. <i>J Am Soc Echocardiogr.</i>2004;17:630-633.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163933</ArticleId></ArticleIdList></Reference><Reference><Citation>Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z. Global longitudinal strain:a novel index of left ventricular systolic function. J Am Soc Echocardiogr. 2004;17:630&#x2013;633.</Citation><ArticleIdList><ArticleId IdType="pubmed">15163933</ArticleId></ArticleIdList></Reference><Reference><Citation>Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. <i>J Am Coll of Cardiol.</i> 2014;63:1972-1981.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657695</ArticleId></ArticleIdList></Reference><Reference><Citation>Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll of Cardiol. 2014;63:1972&#x2013;1981.</Citation><ArticleIdList><ArticleId IdType="pubmed">24657695</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. <i>J Am Soc Echocardiogr.</i> 2015;16:233-271.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr. 2015;16:233&#x2013;271.</Citation><ArticleIdList><ArticleId IdType="pubmed">25559473</ArticleId></ArticleIdList></Reference><Reference><Citation>Notomi Y, Shiota T, Popovic&#xb4;ZB, et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. <i>J Am Coll Cardiol.</i> 2005;45:2034-2041.</Citation><ArticleIdList><ArticleId IdType="pubmed">15963406</ArticleId></ArticleIdList></Reference><Reference><Citation>Notomi Y, Shiota T, Popovic&#xb4; ZB, et al. Measurement of ventricular torsion by two-dimensional ultrasound speckle tracking imaging. J Am Coll Cardiol. 2005;45:2034&#x2013;2041.</Citation><ArticleIdList><ArticleId IdType="pubmed">15963406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundt TM, Jneid H. Guideline update on indications for transcatheter aortic valve implantation based on the 2020 American College of Cardiology/American Heart Association guidelines for management of valvular heart disease. <i>JAMA Cardiol.</i> 2021;6:1088-1089.</Citation><ArticleIdList><ArticleId IdType="pubmed">34287627</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundt TM, Jneid H. Guideline update on indications for transcatheter aortic valve implantation based on the 2020 American College of Cardiology/American Heart Association guidelines for management of valvular heart disease. JAMA Cardiol. 2021;6:1088&#x2013;1089.</Citation><ArticleIdList><ArticleId IdType="pubmed">34287627</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas PS, Berko B, Lesh M, Reichek N. Alterations in diastolic function in response to progressive left ventricular hypertrophy. <i>J Am Coll Cardiol.</i> 1989;13:461-467.</Citation><ArticleIdList><ArticleId IdType="pubmed">2521506</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas PS, Berko B, Lesh M, Reichek N. Alterations in diastolic function in response to progressive left ventricular hypertrophy. J Am Coll Cardiol. 1989;13:461&#x2013;467.</Citation><ArticleIdList><ArticleId IdType="pubmed">2521506</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarracino F, Talini E, Landoni G, Petronio S, Giannini C, Di Bello V. Effect of aortic valve surgery on left ventricular diastole assessed by echocardiography and neuroendocrine response:percutaneous versus surgical approach. <i>J Cardiothorac Vasc Anesth.</i> 2010;24:25-29.</Citation><ArticleIdList><ArticleId IdType="pubmed">19944626</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarracino F, Talini E, Landoni G, Petronio S, Giannini C, Di Bello V. Effect of aortic valve surgery on left ventricular diastole assessed by echocardiography and neuroendocrine response:percutaneous versus surgical approach. J Cardiothorac Vasc Anesth. 2010;24:25&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">19944626</ArticleId></ArticleIdList></Reference><Reference><Citation>Provench&#xe8;re S, Berroeta C, Reynaud C, et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery:association with postoperative cardiac dysfunction and 1-year mortality. <i>Crit Care Med.</i> 2006;34:995-1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484891</ArticleId></ArticleIdList></Reference><Reference><Citation>Provench&#xe8;re S, Berroeta C, Reynaud C, et al. Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery:association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006;34:995&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="pubmed">16484891</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieck &#xc5;E, Gerdts E, L&#xf8;nnebakken MT, et al. Global left ventricular load in asymptomatic aortic stenosis:covariates and prognostic implication (the SEAS trial). <i>Cardiovasc Ultrasound.</i> 2012;10:1-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3542076</ArticleId><ArticleId IdType="pubmed">23126645</ArticleId></ArticleIdList></Reference><Reference><Citation>Rieck &#xc5;E, Gerdts E, L&#xf8;nnebakken MT, et al. Global left ventricular load in asymptomatic aortic stenosis:covariates and prognostic implication (the SEAS trial) Cardiovasc Ultrasound. 2012;10:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3542076</ArticleId><ArticleId IdType="pubmed">23126645</ArticleId></ArticleIdList></Reference><Reference><Citation>Salustri A, Cerquetani E, Piccoli M, et al. Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients. <i>Cardiovasc Ultrasound.</i> 2009;7:1-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779791</ArticleId><ArticleId IdType="pubmed">19863802</ArticleId></ArticleIdList></Reference><Reference><Citation>Salustri A, Cerquetani E, Piccoli M, et al. Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients. Cardiovasc Ultrasound. 2009;7:1&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2779791</ArticleId><ArticleId IdType="pubmed">19863802</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleiziffer S, Ruge H, Mazzitelli D, et al. Survival after transapical and transfemoral aortic valve implantation:talking about two different patient populations. <i>J Thoracic Cardiovasc Surg.</i> 2009;138:1073-1080.</Citation><ArticleIdList><ArticleId IdType="pubmed">19765739</ArticleId></ArticleIdList></Reference><Reference><Citation>Bleiziffer S, Ruge H, Mazzitelli D, et al. Survival after transapical and transfemoral aortic valve implantation:talking about two different patient populations. J Thoracic Cardiovasc Surg. 2009;138:1073&#x2013;1080.</Citation><ArticleIdList><ArticleId IdType="pubmed">19765739</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves A, Marcos-Alberca P, Almeria C, et al. Acute left ventricle diastolic function improvement after transcatheter aortic valve implantation. <i>Eur J Echocardiogr.</i> 2011;12:790-797.</Citation><ArticleIdList><ArticleId IdType="pubmed">21865229</ArticleId></ArticleIdList></Reference><Reference><Citation>Gon&#xe7;alves A, Marcos-Alberca P, Almeria C, et al. Acute left ventricle diastolic function improvement after transcatheter aortic valve implantation. Eur J Echocardiogr. 2011;12:790&#x2013;797.</Citation><ArticleIdList><ArticleId IdType="pubmed">21865229</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha SJ, Yoo SY, Hong MK, Hong GR. Immediate and evolutionary recovery of left ventricular diastolic function after transcatheter aortic valve replacement:comparison with surgery. <i>Yonsei Med J.</i> 2020;61:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938785</ArticleId><ArticleId IdType="pubmed">31887797</ArticleId></ArticleIdList></Reference><Reference><Citation>Ha SJ, Yoo SY, Hong MK, Hong GR. Immediate and evolutionary recovery of left ventricular diastolic function after transcatheter aortic valve replacement:comparison with surgery. Yonsei Med J. 2020;61:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6938785</ArticleId><ArticleId IdType="pubmed">31887797</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbairn TA, Steadman CD, Mather AN, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement:a cardiovascular magnetic resonance study. <i>Heart.</i>2013;99:1185-91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3747520</ArticleId><ArticleId IdType="pubmed">23749779</ArticleId></ArticleIdList></Reference><Reference><Citation>Fairbairn TA, Steadman CD, Mather AN, et al. Assessment of valve haemodynamics, reverse ventricular remodelling and myocardial fibrosis following transcatheter aortic valve implantation compared to surgical aortic valve replacement:a cardiovascular magnetic resonance study. Heart. 2013;99:1185&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3747520</ArticleId><ArticleId IdType="pubmed">23749779</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo A, Hassager C, Thyregod HGH, et al. Differences in left ventricular remodelling in patients with aortic stenosis treated with transcatheter aortic valve replacement with corevalve prostheses compared to surgery with porcine or bovine biological prostheses. <i>Eur Heart J Cardiovasc Imaging.</i> 2018;19:39-46.</Citation><ArticleIdList><ArticleId IdType="pubmed">28158582</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngo A, Hassager C, Thyregod HGH, et al. Differences in left ventricular remodelling in patients with aortic stenosis treated with transcatheter aortic valve replacement with corevalve prostheses compared to surgery with porcine or bovine biological prostheses. Eur Heart J Cardiovasc Imaging. 2018;19:39&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">28158582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempny A, Diller GP, Kaleschke G, et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. <i>Heart.</i> 2012;98:1299-304</Citation><ArticleIdList><ArticleId IdType="pubmed">22689711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempny A, Diller GP, Kaleschke G, et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. Heart. 2012;98:1299&#x2013;304.</Citation><ArticleIdList><ArticleId IdType="pubmed">22689711</ArticleId></ArticleIdList></Reference><Reference><Citation>Weideman F, Jamal F, Kowalski M, et al. Can strain rate and strain quantify changes in regional systolic function during dobutamine infusion, B-blockade, and atrial pacing &#x2014;implications for quantitative stress echocardiography. <i>J Am Soc Echocardiogr.</i>2002;15:416-424.</Citation><ArticleIdList><ArticleId IdType="pubmed">12019424</ArticleId></ArticleIdList></Reference><Reference><Citation>Weideman F, Jamal F, Kowalski M, et al. Can strain rate and strain quantify changes in regional systolic function during dobutamine infusion, B-blockade, and atrial pacing &#x2014;implications for quantitative stress echocardiography. J Am Soc Echocardiogr. 2002;15:416&#x2013;424.</Citation><ArticleIdList><ArticleId IdType="pubmed">12019424</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado V, Tops LF, van Bommel RJ, et al. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. <i>Eur Heart J.</i> 2009;30:3037-3047.</Citation><ArticleIdList><ArticleId IdType="pubmed">19726436</ArticleId></ArticleIdList></Reference><Reference><Citation>Delgado V, Tops LF, van Bommel RJ, et al. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J. 2009;30:3037&#x2013;3047.</Citation><ArticleIdList><ArticleId IdType="pubmed">19726436</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini C, Petronio AS, Talini E, et al. Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis:an echocardiographic study. <i>Am J Cardiovasc Dis.</i> 2011;1:264-273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253517</ArticleId><ArticleId IdType="pubmed">22254204</ArticleId></ArticleIdList></Reference><Reference><Citation>Giannini C, Petronio AS, Talini E, et al. Early and late improvement of global and regional left ventricular function after transcatheter aortic valve implantation in patients with severe aortic stenosis:an echocardiographic study. Am J Cardiovasc Dis. 2011;1:264&#x2013;273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3253517</ArticleId><ArticleId IdType="pubmed">22254204</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempny A, Diller GP, Kaleschke G, et al. Longitudinal left ventricular 2D strain is superior to ejection fraction in predicting myocardial recovery and symptomatic improvement after aortic valve implantation. <i>Int J Cardiol.</i> 2013;167:2239-2243.</Citation><ArticleIdList><ArticleId IdType="pubmed">22766243</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempny A, Diller GP, Kaleschke G, et al. Longitudinal left ventricular 2D strain is superior to ejection fraction in predicting myocardial recovery and symptomatic improvement after aortic valve implantation. Int J Cardiol. 2013;167:2239&#x2013;2243.</Citation><ArticleIdList><ArticleId IdType="pubmed">22766243</ArticleId></ArticleIdList></Reference><Reference><Citation>Schattke S, Baldenhofer G, Prauka I, et al. Acute regional improvement of myocardial function after interventional transfemoral aortic valve replacement in aortic stenosis:A speckle tracking echocardiography study. <i>Cardiovasc Ultrasound.</i> 2012;10:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3344694</ArticleId><ArticleId IdType="pubmed">22448716</ArticleId></ArticleIdList></Reference><Reference><Citation>Schattke S, Baldenhofer G, Prauka I, et al. Acute regional improvement of myocardial function after interventional transfemoral aortic valve replacement in aortic stenosis:A speckle tracking echocardiography study. Cardiovasc Ultrasound. 2012;10:15.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3344694</ArticleId><ArticleId IdType="pubmed">22448716</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Panoulas V, Jabbour RJ, et al. Left ventricular speckle tracking echocardiographic evaluation before and after TAVI. <i>Echo Res Pract.</i> 2020;7:29-38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487179</ArticleId><ArticleId IdType="pubmed">36472209</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsampasian V, Panoulas V, Jabbour RJ, et al. Left ventricular speckle tracking echocardiographic evaluation before and after TAVI. Echo Res Pract. 2020;7:29&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7487179</ArticleId><ArticleId IdType="pubmed">36472209</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;MP, Jacquemyn X, Van den Eynde J, et al. Impact of Paravalvular Leak on Outcomes After Transcatheter Aortic Valve Implantation:Meta-Analysis of Kaplan-Meier-derived Individual Patient Data. <i>Struct Heart.</i> 2023;7:100118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10236885</ArticleId><ArticleId IdType="pubmed">37275584</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1; MP, Jacquemyn X, Van den Eynde J, et al. Impact of Paravalvular Leak on Outcomes After Transcatheter Aortic Valve Implantation:Meta-Analysis of Kaplan-Meier-derived Individual Patient Data. Struct Heart. 2023;7:100118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10236885</ArticleId><ArticleId IdType="pubmed">37275584</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampaktsis PN, Subramayam P, Sherifi I, et al. Impact of paravalvular leak on left ventricular remodeling and global longitudinal strain 1 year after transcatheter aortic valve replacement. <i>Future Cardiology.</i> 2021;17:337-345.</Citation><ArticleIdList><ArticleId IdType="pubmed">33590775</ArticleId></ArticleIdList></Reference><Reference><Citation>Kampaktsis PN, Subramayam P, Sherifi I, et al. Impact of paravalvular leak on left ventricular remodeling and global longitudinal strain 1 year after transcatheter aortic valve replacement. Future Cardiology. 2021;17:337&#x2013;345.</Citation><ArticleIdList><ArticleId IdType="pubmed">33590775</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">40222322</PMID><DateCompleted><Year>2025</Year><Month>06</Month><Day>24</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>26</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-8989</ISSN><JournalIssue CitedMedium="Internet"><Volume>164</Volume><Issue>12</Issue><PubDate><Year>2025</Year><Month>Jun</Month><Day>27</Day></PubDate></JournalIssue><Title>Medicina clinica</Title><ISOAbbreviation>Med Clin (Barc)</ISOAbbreviation></Journal><ArticleTitle>Geriatric assessment and results of transcatheter aortic valve implantation.</ArticleTitle><Pagination><StartPage>106936</StartPage><MedlinePgn>106936</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.medcli.2025.106936</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0025-7753(25)00130-7</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Comprehensive geriatric assessment (CGA) prior to transcatheter aortic valve replacement implantation (TAVI) for severe aortic stenosis (AS) may improve the selection of patients targeted for this strategy. Despite the fact that CGA includes multiple scales, comparative data among them are limited. Our aim was to evaluate the discriminative capacity of different scales used in CGA on the decision of suitability for TAVI implantation and the influence on prognosis after TAVI implantation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Single-center prospective observational study including consecutive patients with severe AS referred for TAVI implantation. A CGA was performed in all patients including scales of functionality, frailty, cognitive impairment and comorbidities. The predictive capacity of each of the scales was evaluated. The development of major adverse cardiovascular events (MACE: cardiovascular mortality, heart failure [HF] and stroke) was analyzed during follow-up.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 142 patients were selected as candidates for TAVI (80.2%), and 121 were finally implanted. The mean age was 83&#xb1;4.9 years. Patients who were candidates for TAVI had less valvular area, less atrial fibrillation (AF), less cognitive impairment, more autonomy and less frailty. The SPPB frailty and Barthel functional assessment scales were the main scales of the CGA for the TAVI candidacy decision. After TAVI implantation, 21.5% presented a MACE event, with an overall mortality of 19.8% (6.6% cardiovascular). Patients with a higher rate of events and mortality had more AF, HF, renal disease and malnutrition, as well as less family coverage.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In elderly patients with severe AS, the CGA is a determining factor in the selection of candidates for TAVI, with frailty and functional assessment being the most important aspects. Family support and nutritional status have a high impact on the prognosis of patients after TAVI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de la Rubia-Molina</LastName><ForeName>Cristina</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Servicio de Geriatr&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cubides-Novoa</LastName><ForeName>Andrez Felipe</ForeName><Initials>AF</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Madrid-L&#xf3;pez</LastName><ForeName>Mar&#xed;a Teresa</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Servicio de Geriatr&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pat&#xed;n-Gonz&#xe1;lez</LastName><ForeName>Elisa</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Servicio de Geriatr&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Merch&#xe1;n-Ordo&#xf1;ez</LastName><ForeName>Ver&#xf3;nica</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Servicio de Geriatr&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Negreira-Caama&#xf1;o</LastName><ForeName>Mart&#xed;n</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital Universitario 12 de Octubre, Madrid, Espa&#xf1;a; Instituto de investigaci&#xf3;n Hospital 12 de Octubre (iMAS12), Madrid, Espa&#xf1;a. Electronic address: martin.negcam@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gil-Moreno</LastName><ForeName>Javier</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Geriatr&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Freites</LastName><ForeName>Alfonso</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a; Facultad de Medicina, Universidad de Castilla-La Mancha, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>S&#xe1;nchez-P&#xe9;rez</LastName><ForeName>Ignacio</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a; Facultad de Medicina, Universidad de Castilla-La Mancha, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazoteras-Mu&#xf1;oz</LastName><ForeName>Virginia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Servicio de Geriatr&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a; Facultad de Medicina, Universidad de Castilla-La Mancha, Ciudad Real, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piqueras-Flores</LastName><ForeName>Jes&#xfa;s</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Servicio de Cardiolog&#xed;a, Hospital General Universitario de Ciudad Real, Ciudad Real, Espa&#xf1;a; Facultad de Medicina, Universidad de Castilla-La Mancha, Ciudad Real, Espa&#xf1;a; Instituto de Investigaci&#xf3;n Sanitaria de Castilla-La Mancha (IDISCAM), Toledo, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><VernacularTitle>Impacto de la valoraci&#xf3;n geri&#xe1;trica en el resultado del reemplazo percut&#xe1;neo de la v&#xe1;lvula a&#xf3;rtica.</VernacularTitle><ArticleDate DateType="Electronic"><Year>2025</Year><Month>04</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Med Clin (Barc)</MedlineTA><NlmUniqueID>0376377</NlmUniqueID><ISSNLinking>0025-7753</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015577" MajorTopicYN="Y">Geriatric Assessment</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073496" MajorTopicYN="N">Frailty</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018579" MajorTopicYN="Y">Patient Selection</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="N">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic stenosis</Keyword><Keyword MajorTopicYN="N">Cardio-geriatrics</Keyword><Keyword MajorTopicYN="N">Cardiogeriatr&#xed;a</Keyword><Keyword MajorTopicYN="N">Comprehensive geriatric assessment</Keyword><Keyword MajorTopicYN="N">Estenosis a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Fragilidad</Keyword><Keyword MajorTopicYN="N">Frailty</Keyword><Keyword MajorTopicYN="N">Implante transcat&#xe9;ter de pr&#xf3;tesis a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Transcatheter aortic valve implantation</Keyword><Keyword MajorTopicYN="N">Valoraci&#xf3;n geri&#xe1;trica integral</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2025</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2025</Year><Month>1</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>6</Month><Day>24</Day><Hour>13</Hour><Minute>15</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>4</Month><Day>14</Day><Hour>0</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>4</Month><Day>13</Day><Hour>18</Hour><Minute>7</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">40222322</ArticleId><ArticleId IdType="doi">10.1016/j.medcli.2025.106936</ArticleId><ArticleId IdType="pii">S0025-7753(25)00130-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39461471</PMID><DateCompleted><Year>2025</Year><Month>05</Month><Day>28</Day></DateCompleted><DateRevised><Year>2025</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1885-5857</ISSN><JournalIssue CitedMedium="Internet"><Volume>78</Volume><Issue>6</Issue><PubDate><Year>2025</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Revista espanola de cardiologia (English ed.)</Title><ISOAbbreviation>Rev Esp Cardiol (Engl Ed)</ISOAbbreviation></Journal><ArticleTitle>Aortic valve calcification volume and prognosis in patients undergoing transcatheter aortic valve implantation.</ArticleTitle><Pagination><StartPage>507</StartPage><EndPage>518</EndPage><MedlinePgn>507-518</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rec.2024.10.005</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S1885-5857(24)00310-4</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND OBJECTIVES" NlmCategory="OBJECTIVE">It is unknown whether aortic valve calcium volume, as measured by contrast-enhanced computed tomography angiography (angio-CT), is associated with mortality in patients undergoing transcatheter aortic valve implantation (TAVI). We aimed to confirm that contrast-enhanced aortic valve calcium correlates with noncontrast-enhanced calcium score and provides useful prognostic information in patients undergoing TAVI.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective observational study included patients from 2 high-volume TAVI centers in Germany, all of whom underwent high-quality angio-CT prior to TAVI. Calcium volume in contrast-enhanced angio-CT was calculated using 3Mensio software (Pie Medical, The Netherlands), while the calcium score from noncontrast-enhanced angio-CT was obtained using the Syngo.via (Siemens Healthineers, Germany) workstation to validate contrast-enhanced angio-CT values. Calcium volume was dichotomized using the median based on to sex-specific values from contrast-enhanced angio-CT, and the risk associated with increased calcium volume was determined using Cox proportional hazard regression analysis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We included 3318 TAVI patients. A good correlation was observed between noncontrast-enhanced and contrast-enhanced angio-CT (r<sup>2</sup>=0.680; P&lt;.001). The median values for sex-specific contrast-enhanced angio-CT calcium volume were 514 mm<sup>3</sup> for women and 1025 mm<sup>3</sup> for men. Patients with higher calcium volumes showed lower mortality at 1 year (8.8% vs 12.1%; adjusted HR, 0.86; 95%CI, 0.75-0.98; P=.02) compared with those with lower calcium volumes.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Calcium volume in contrast-enhanced angio-CT correlated well with noncontrast-enhanced angio-CT calcium score. Patients with higher calcium volume showed lower mortality at 1 year after TAVI.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Sociedad Espa&#xf1;ola de Cardiolog&#xed;a. Published by Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>&#xc1;lvarez-Covarrubias</LastName><ForeName>H&#xe9;ctor A</ForeName><Initials>HA</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany; Departamento de Cardiolog&#xed;a, Hospital de Cardiolog&#xed;a, Centro M&#xe9;dico Nacional Siglo XXI, Instituto Mexicano del Seguro (IMSS), M&#xe9;xico City, Mexico. Electronic address: alvarez@dhm.mhn.de.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Altaner</LastName><ForeName>Niklas</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Adolf</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Radiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jurisic</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Horban</LastName><ForeName>Elisabeth</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pellegrini</LastName><ForeName>Costanza</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duesmann</LastName><ForeName>Charlotte</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lachmann</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>First Department of Medicine, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thilo</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Cardiology, RoMed Klinikum Rosenheim, Rosenheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Syryca</LastName><ForeName>Finn</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klos</LastName><ForeName>Markus</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Medicum Tegernsee, Rottach-Weissach, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mayr</LastName><ForeName>N Patrick</ForeName><Initials>NP</Initials><AffiliationInfo><Affiliation>Institut f&#xfc;r An&#xe4;sthesiologie, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rheude</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renker</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Kerckhoff Klinik, Bad Nauheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Charitos</LastName><ForeName>Efstratios I</ForeName><Initials>EI</Initials><AffiliationInfo><Affiliation>Department of Cardiac Surgery, Kerckhoff Klinik, Bad Nauheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schunkert</LastName><ForeName>Heribert</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kastrati</LastName><ForeName>Adnan</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xhepa</LastName><ForeName>Erion</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Won-Keun</LastName><ForeName>Kim</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Kerckhoff Klinik, Bad Nauheim, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Joner</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Cardiology, Deutsches Herzzentrum M&#xfc;nchen, Technische Universit&#xe4;t M&#xfc;nchen, Munich, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Munich Heart Alliance, Munich, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>spa</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Esp Cardiol (Engl Ed)</MedlineTA><NlmUniqueID>101587954</NlmUniqueID><ISSNLinking>1885-5857</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Disease" UI="C562942">Aortic Valve, Calcification of</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="Y">Aortic Valve</DescriptorName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002114" MajorTopicYN="Y">Calcinosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000000981" MajorTopicYN="N">diagnostic imaging</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000072226" MajorTopicYN="N">Computed Tomography Angiography</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005858" MajorTopicYN="N" Type="Geographic">Germany</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic valve calcification</Keyword><Keyword MajorTopicYN="N">Aortic valve stenosis</Keyword><Keyword MajorTopicYN="N">Calcificaci&#xf3;n valvular a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Calcium volume</Keyword><Keyword MajorTopicYN="N">Estenosis valvular a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Implante percut&#xe1;neo de v&#xe1;lvula a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Transcatheter aortic valve implantation</Keyword><Keyword MajorTopicYN="N">Volumen de calcio</Keyword></KeywordList><CoiStatement>CONFLICTS OF INTEREST H.A. &#xc1;lvarez-Covarrubias received lecture fees from SIS Medical AG, LifeTech and Edward Lifesciences, not related to the current work. T. Rheude received lecture fees from AstraZeneca, Abbott, SIS Medical and Translumina and a travel grant to the institution from Boston Scientific; not related to this work. M. Renker received proctor fees from Boston Scientific; not related to the current work. H. Schunkert reports personal fees from AMGEN, Daiichi-Sankyo, MSD Sharp &amp; Dohme, Astra Zeneca, Bazer Vital, Boehringer-Ingelheim, Novartis, Servier, Sanofi Aventis, and Synlab, not related to the current work. E. Xhepa reports lecture fees from Astra Zeneca, Boston Scientific, SIS Medical, and financial support from Abbott Vascular, not related to the current work. M. Joner reports personal fees from Abbott, Alchimedics S.A.S., Astra Zeneca, Biotronik, Medtronic, Recor, Shockwave, TriCares, and Veryan, grants and personal fees from Boston Scientific, and Cardiac Dimensions, Edwards, and a grant from Infraredx outside the submitted work. The remaining authors have no conflicts of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>5</Month><Day>29</Day><Hour>0</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>27</Day><Hour>17</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39461471</ArticleId><ArticleId IdType="doi">10.1016/j.rec.2024.10.005</ArticleId><ArticleId IdType="pii">S1885-5857(24)00310-4</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38401703</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2174-2030</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology</Title><ISOAbbreviation>Rev Port Cardiol</ISOAbbreviation></Journal><ArticleTitle>Surgical aortic valve replacement in octogenarians: Single-center perioperative outcomes and five-year survival.</ArticleTitle><Pagination><StartPage>311</StartPage><EndPage>320</EndPage><MedlinePgn>311-320</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.repc.2024.02.003</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0870-2551(24)00069-6</ELocationID><Abstract><AbstractText Label="INTRODUCTION AND OBJECTIVES">Aortic stenosis is the most common valvular heart disease. The number of octogenarians proposed for intervention is growing due to increased lifespan. In this manuscript we aim to evaluate perioperative outcome and long-term survival after surgical aortic valve replacement (SAVR) in octogenarians, comparing patients with low surgical risk (EuroscoreII &lt;4%) with intermediate-high risk (EuroscoreII &#x2265;4%).</AbstractText><AbstractText Label="METHODS">A retrospective observational single-center cohort study with 195 patients aged &#x2265;80 years old, who underwent SAVR between 2017 and 2021, was conducted. Patients were divided into two groups according to EuroscoreII: (1) Low risk (EuroscoreII &lt;4%) with intermediate-high risk (EuroscoreII &#x2265;4%). Continuous variables are presented in median (IQR), analyzed using Wilcoxon rank sum test; categorical variables in percentages, analyzed using chi-squared test; and survival was analyzed by Kaplan-Meier, open cohort, and the log-rank test was performed.</AbstractText><AbstractText Label="RESULTS">The overall median age was 82 (IQR 81-83), with 4.6% of the patients &#x2265;85 years old. 23.6% of the patients presented EuroscoreII &#x2265;4%. No complications were observed in 26.2%, with a significantly higher rate in intermediate-high risk patients. Postoperative need for hemodynamic support was the most frequent complication, followed by postoperative acute kidney injury and the use of blood products. Overall median ICU stay was three days (2-4) and hospital length of stay (LOS) six days (5-8). Patients with intermediate-high risk and those with complications had longer ICU LOS. At 12 months, overall survival was 96.4%, at three years 94.1% and 5 years 75.4%. Patients with low surgical risk had higher survival proportions up to 5 years.</AbstractText><AbstractText Label="CONCLUSION">SAVR in patients &#x2265;80 years is associated with low in-hospital mortality, although a significant proportion of patients develop complications. Long-term follow-up up to five years after surgery is acceptable in octogenarians with low surgical risk.</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Velho</LastName><ForeName>Tiago R</ForeName><Initials>TR</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal; Cardiothoracic Surgery Research Unit, Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Faculdade de Medicina da Universidade de Lisboa, Lisbon, Portugal; Innate Immunity and Inflammation Laboratory, Instituto Gulbenkian de Ci&#xea;ncia, Oeiras, Portugal. Electronic address: tiagovelho48@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gon&#xe7;alves</LastName><ForeName>Jo&#xe3;o</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mani&#xe9;s Pereira</LastName><ForeName>Rafael</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal; Escola Superior de Sa&#xfa;de da Cruz Vermelha Portuguesa, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferreira</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sena</LastName><ForeName>Andr&#xe9;</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Junqueira</LastName><ForeName>N&#xe1;dia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>&#xc2;ngelo</LastName><ForeName>Eur&#xed;dice</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Carvalho Guerra</LastName><ForeName>Nuno</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mendes</LastName><ForeName>M&#xe1;rio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arruda Pereira</LastName><ForeName>Ricardo</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nobre</LastName><ForeName>&#xc2;ngelo</ForeName><Initials>&#xc2;</Initials><AffiliationInfo><Affiliation>Cardiothoracic Surgery Department, Hospital de Santa Maria, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, EPE, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>02</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Portugal</Country><MedlineTA>Rev Port Cardiol</MedlineTA><NlmUniqueID>8710716</NlmUniqueID><ISSNLinking>0870-2551</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000369" MajorTopicYN="N">Aged, 80 and over</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001021" MajorTopicYN="N">Aortic Valve</DescriptorName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Aortic valve replacement</Keyword><Keyword MajorTopicYN="N">Aortic valve stenosis</Keyword><Keyword MajorTopicYN="N">Cardiac surgery</Keyword><Keyword MajorTopicYN="N">Cirurgia card&#xed;aca</Keyword><Keyword MajorTopicYN="N">Elderly</Keyword><Keyword MajorTopicYN="N">Estenose a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Idosos</Keyword><Keyword MajorTopicYN="N">Octogenarians</Keyword><Keyword MajorTopicYN="N">Octogen&#xe1;rios</Keyword><Keyword MajorTopicYN="N">Substitui&#xe7;&#xe3;o v&#xe1;lvula a&#xf3;rtica</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>2</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>3</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>2</Month><Day>25</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>2</Month><Day>24</Day><Hour>19</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38401703</ArticleId><ArticleId IdType="doi">10.1016/j.repc.2024.02.003</ArticleId><ArticleId IdType="pii">S0870-2551(24)00069-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37889128</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>30</Day></DateCompleted><DateRevised><Year>2024</Year><Month>02</Month><Day>03</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1576-6578</ISSN><JournalIssue CitedMedium="Internet"><Volume>77</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Nov</Month><Day>01</Day></PubDate></JournalIssue><Title>Revista de neurologia</Title><ISOAbbreviation>Rev Neurol</ISOAbbreviation></Journal><ArticleTitle>[Delayed cognitive impairment in patients with aortic stenosis treated with surgical valve replacement and transcatheter aortic valve implantation: a comparative study].</ArticleTitle><Pagination><StartPage>205</StartPage><EndPage>214</EndPage><MedlinePgn>205-214</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.33588/rn.7709.2022346</ELocationID><Abstract><AbstractText Label="INTRODUCTION">Cognitive impairment secondary to cerebrovascular events is a common complication of aortic valve replacement interventions. Our aim is to study the deterioration profile of patients who have undergone surgical valve replacement or transcatheter valve implantation (TAVI) and whether it differs according to the intervention they underwent and their baseline risk factors.</AbstractText><AbstractText Label="PATIENTS AND METHODS">We conducted a prospective observational study with two non-equivalent groups of patients (TAVI group and surgical group) Intergroup comparisons were carried out in several cognitive domains, with a baseline assessment and follow-up measurements six and 12 months after the intervention.</AbstractText><AbstractText Label="RESULTS">The TAVI group performed less well than the surgical group in executive and visuospatial functions, with scores partially determined by age (p &lt; 0.01) and prior intellectual level (Pearson prior intelligence quotient-scalar test means: 0.665; p &lt; 0.001). Mean scores at the three measurement points indicate a decline in executive function performance at six months, which is restored at 12 months. Sustained increases in memory were recorded at both time points, while visuospatial function and naming showed no subsequent recovery of the baseline levels. These trends are similar in both groups.</AbstractText><AbstractText Label="CONCLUSION">The results obtained do not confirm the appearance of a specific process of post-intervention neurocognitive impairment in complicated aortic stenosis. The deterioration profile does not show any significant differences between groups, but is more evident in TAVI patients, due to the influence of variables related to sample selection.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>D&#xed;az-Leiva</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arrondo-G&#xf3;mez</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Fundaci&#xf3;n Cl&#xed;nica Josefina Arregui, Alsasua, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alonso-Send&#xed;n</LastName><ForeName>E</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gainza-Calleja</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ostolaza-Ib&#xe1;&#xf1;ez</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tellechea-Aramburo</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf3;mez-Blasco</LastName><ForeName>F</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco-Berega&#xf1;a</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>L&#xf3;pez-Sala</LastName><ForeName>P</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabada-Giad&#xe1;s</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Navarra, Pamplona, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author></AuthorList><Language>spa</Language><PublicationTypeList><PublicationType UI="D064888">Observational Study</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Deterioro cognitivo tard&#xed;o en pacientes con estenosis a&#xf3;rtica tratados con sustituci&#xf3;n valvular quir&#xfa;rgica y con implantaci&#xf3;n transcat&#xe9;ter de v&#xe1;lvula a&#xf3;rtica: estudio comparativo.</VernacularTitle></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Rev Neurol</MedlineTA><NlmUniqueID>7706841</NlmUniqueID><ISSNLinking>0210-0010</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D065467" MajorTopicYN="Y">Transcatheter Aortic Valve Replacement</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019918" MajorTopicYN="Y">Heart Valve Prosthesis Implantation</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018570" MajorTopicYN="N">Risk Assessment</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001024" MajorTopicYN="Y">Aortic Valve Stenosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D060825" MajorTopicYN="Y">Cognitive Dysfunction</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013525" MajorTopicYN="N">Surgical Instruments</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="TITLE">Deterioro cognitivo tard&#xed;o en pacientes con estenosis a&#xf3;rtica tratados con sustituci&#xf3;n valvular quir&#xfa;rgica y con implantaci&#xf3;n transcat&#xe9;ter de v&#xe1;lvula a&#xf3;rtica: estudio comparativo.</AbstractText><AbstractText Label="UNLABELLED">Introducci&#xf3;n. El deterioro cognitivo secundario a eventos cerebrovasculares es una complicaci&#xf3;n frecuente en las intervenciones de reemplazo de v&#xe1;lvula a&#xf3;rtica. Nuestro objetivo es el estudio del perfil de deterioro de los pacientes sometidos a reemplazo valvular quir&#xfa;rgico o implantaci&#xf3;n de pr&#xf3;tesis transcat&#xe9;ter (TAVI) y si &#xe9;ste resulta diferente seg&#xfa;n la intervenci&#xf3;n a la que son sometidos y los factores de riesgo basales. Pacientes y m&#xe9;todos. Estudio observacional prospectivo, con dos grupos no equivalentes de pacientes (grupo TAVI y grupo quir&#xfa;rgico). Se realizaron comparaciones intergrupo en varios dominios cognitivos, con una evaluaci&#xf3;n basal y mediciones de seguimiento seis y 12 meses despu&#xe9;s la intervenci&#xf3;n. Resultados. El grupo TAVI present&#xf3; resultados inferiores al grupo quir&#xfa;rgico en funciones ejecutivas y visuoespaciales, puntuaciones parcialmente determinadas por la edad (p &lt; 0,01) y el nivel intelectual previo (Pearson cociente intelectual previo-medias escalares en los test: 0,665; p &lt; 0,001). La media de puntuaciones en los tres momentos de medici&#xf3;n indica una disminuci&#xf3;n del rendimiento en funciones ejecutivas a los seis meses, que se recupera a los 12 meses. En memoria se registraron incrementos sostenidos en ambos momentos, en tanto que la funci&#xf3;n visuoespacial y la denominaci&#xf3;n no mostraron recuperaci&#xf3;n posterior de los niveles basales. Estas tendencias son similares en los dos grupos. Conclusi&#xf3;n. Los resultados obtenidos no confirman la instauraci&#xf3;n de un proceso espec&#xed;fico de deterioro neurocognitivo postintervenci&#xf3;n en la estenosis a&#xf3;rtica complicada. El perfil de deterioro no presenta diferencias significativas entre los grupos, pero es m&#xe1;s evidente en los pacientes con TAVI, debido a la influencia de las variables de selecci&#xf3;n de la muestra.</AbstractText></OtherAbstract><CoiStatement>Conflicto de intereses: No declarado.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>30</Day><Hour>6</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>27</Day><Hour>9</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>11</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37889128</ArticleId><ArticleId IdType="pmc">PMC10831739</ArticleId><ArticleId IdType="doi">10.33588/rn.7709.2022346</ArticleId><ArticleId IdType="pii">rn2022346</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ramos-Jim&#xe9;nez J, Hern&#xe1;ndez-Jim&#xe9;nez S, Vi&#xe9;itez-Fl&#xf3;rez JM, Alonso-Salinas GL, Zamorano-G&#xf3;mez JL. Cribado poblacional de estenosis a&#xf3;rtica:prevalencia y perfil de riesgo. Rev Esp Cardiol. 2021;56:77&#x2013;84.</Citation></Reference><Reference><Citation>Ancona R, Comenale Pinto S. Epidemiology of aortic valve stenosis (AS) and of aortic valve incompetence (AI):is the prevalence of AS/AI similar in different parts of the world?  URL: https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-18/epidemiology-of-aortic-valve-stenosis-as-and-of-aortic-valve-incompetence-ai . Fecha &#xfa;ltima consulta:12.02.2020.</Citation></Reference><Reference><Citation>Beyersdorf F, Vahanian A, Milojevic M, Praz F, Baldus S, Bauersachs J, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease:developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur J Cardiothorac Surg. 2021;60:727&#x2013;800.</Citation><ArticleIdList><ArticleId IdType="pubmed">34453161</ArticleId></ArticleIdList></Reference><Reference><Citation>Leon MB, Smith CR, Mack M, Craig Miller D, Moses JW, Svensson LG, et al. Transcatheter aortic-valve implantaction for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597&#x2013;607.</Citation><ArticleIdList><ArticleId IdType="pubmed">20961243</ArticleId></ArticleIdList></Reference><Reference><Citation>Keage H, Smith A, Loetscher T, Psaltis P. Cognitive outcomes of cardiovascular surgical procedures in the old:an important but neglected area. Heart Lung Circ. 2016;25:1148&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">27726955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanem A, D&#xf6;rner J, Schulze-Hagen L, M&#xfc;ller A, Wilsing M, Sinning JM, et al. Subacute subclinical brain infarctions after transcatheter aortic valve implantation negatively impact cognitive function in long-term follow-up. PLoS One. 2017;12:e0168852.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5215955</ArticleId><ArticleId IdType="pubmed">28056466</ArticleId></ArticleIdList></Reference><Reference><Citation>Doerner J, Kupczyk PA, Wilsing M, Luetkens JA, Storm K, Fimmers R, et al. Cerebral white matter lesion burden is associated with the degree of aortic valve calcification and predicts peri-procedural cerebrovascular events in patients undergoing transcatheter aortic valve implantation (TAVI) Catheter Cardiovasc Interv. 2018;91:774&#x2013;82.</Citation><ArticleIdList><ArticleId IdType="pubmed">28547872</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdul-Jawad Altisent O, Ferreira-Gonzalez I, Marsal JR, Ribera A, Auger C, Ortega G, et al. Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients. Clin Res Cardiol. 2016;105:508&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pubmed">26646556</ArticleId></ArticleIdList></Reference><Reference><Citation>Knipp SC, Kahlertb P, Jokischc D, Schlamannd M, Wendta D, Weimarc C, et al. Cognitive function after transapical aortic valve implantation:a single-centre study with 3-month follow-up. Interact Cardiovasc Thorac Surg. 2013;16:116&#x2013;22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3548540</ArticleId><ArticleId IdType="pubmed">23148084</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggebrecht H, Schmermund A, Voigtlander T, Kahlert P, Erbel R, Mehta RH. Risk of stroke after transcatheter aortic valve implantation (TAVI):a meta-analysis of 10,037 published patients. EuroIntervention. 2012;8:129&#x2013;38.</Citation><ArticleIdList><ArticleId IdType="pubmed">22391581</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams DH, Popma JJ, Reardon MJ. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med. 2014;371:967&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25184874</ArticleId></ArticleIdList></Reference><Reference><Citation>American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 5th ed. Washington, DC: American Psychiatric Association; 2013.</Citation></Reference><Reference><Citation>Del Ser T, Gonz&#xe1;lez-Montalvo JI, Mart&#xed;nez-Espinosa S, Delgado-Villapalos C, Bermejo F. Estimation of premorbid intelligence in Spanish people with the word accentuation test and its application to the diagnosis of dementia. Brain Cogn. 1997;33:343&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">9126399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson B, Alderman N, Burgess PW, Emslie H, Evans J. Behavioural Assessment of the Dysexecutive Syndrome (BADS) J Occup Psychol Employ Disabil. 2003;17:17&#x2013;32.</Citation></Reference><Reference><Citation>Pe&#xf1;a-Casanova J, Qui&#xf1;ones-Ubeda S, Gramunt-Fombuena N, Quintana-Aparicio M, Aguilar M, Badenes D, et al. Spanish Multicenter Normative Studies (NEURONORMA Project):norms for verbal fluency tests. Arch Clin Neuropsychol. 2009;24:395&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pubmed">19648583</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Casanova J, Qui&#xf1;ones-Ubeda S, Quintana-Aparicio M, Aguilar M, Badenes D, Molinuevo JL, et al. Spanish Multicenter Normative Studies (NEURONORMA Project):norms for verbal span, visuospatial span, letter and number sequencing, trail making test, and symbol digit modalities test. Arch Clin Neuropsychol. 2009;24:321&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pubmed">19661109</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Casanova J, Qui&#xf1;ones-Ubeda S, Gramunt-Fombuena N, Quintana M, Aguilar M, Molinuevo JL, et al. Spanish Multicenter Normative Studies (NEURONORMA Project):norms for the Stroop color-word interference test and the Tower of London-Drexel. Arch Clin Neuropsychol. 2009;24:413&#x2013;29.</Citation><ArticleIdList><ArticleId IdType="pubmed">19661108</ArticleId></ArticleIdList></Reference><Reference><Citation>Pe&#xf1;a-Casanova J, Gramunt-Fombuena N, Qui&#xf1;ones-&#xda;beda S, S&#xe1;nchez-Benavides G, Aguilar M, Badenes D, et al. Spanish Multicenter Normative Studies (NEURONORMA Project):norms for the Rey-Osterrieth Complex Figure (Copy and Memory), and Free and Cued Selective Reminding Test. Arch Clin Neuropsychol. 2009;24:371&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pubmed">19661107</ArticleId></ArticleIdList></Reference><Reference><Citation>Selnes OA, Gottesman RF, Grega MA, Baumgartner WA, Zeger SL, McKhann GM. Cognitive and neurologic outcomes after coronary-artery bypass surgery. N Engl J Med. 2012;366:250&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">22256807</ArticleId></ArticleIdList></Reference><Reference><Citation>Terrando N, Eriksson LI, Ryu JK, Yang T, Monaco C, Feldmann M, et al. Resolving postoperative neuroinflammation and cognitive decline. Ann Neurol. 2011;70:986&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4556354</ArticleId><ArticleId IdType="pubmed">22190370</ArticleId></ArticleIdList></Reference><Reference><Citation>Hovens IB, Schoemaker RG, van der Zee EA, Heineman E, Izaks GJ, van Leeuwen BL. Thinking through postoperative cognitive dysfunction:how to bridge the gap between clinical and pre-clinical perspectives. Brain Behav Immun. 2012;26:1169&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">22728316</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasiadis K, Argiriadou H, Kosmidis MH, Megari K, Antonitsis P, Thomaidou E, et al. Neurocognitive outcome after coronary artery bypass surgery using minimal versus conventional extracorporeal circulation:a randomised controlled pilot study. Heart. 2011;97:1082&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">21357641</ArticleId></ArticleIdList></Reference><Reference><Citation>P&#xe9;rez-Belmonte LM, Lara JP, Olalla-Mercad&#xe9; E, Guti&#xe9;rrez de Loma J, Barbancho MA, San Rom&#xe1;n-Ter&#xe1;n CM. Deterioro cognitivo en pacientes con enfermedad coronaria:relaci&#xf3;n con variables cl&#xed;nicas. Med Clin (Barc) 2014;143:109&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">24361158</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann GM, Grega MA, Borowicz LM, Bailey MM, Barry SJ, Zeger SL, et al. Is there cognitive decline 1 year after CABG?Comparison with surgical and nonsurgical controls. Neurology. 2005;65:991&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">16107605</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dijk D, Jansen EW, Hijman R, Nierich AP, Diephuis JC, Moons KG, et al. Cognitive outcome after off-pump and on-pump coronary artery bypass graft surgery:a randomized trial. JAMA. 2002;287:1405&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pubmed">11903027</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Dijk D, Spoor M, Hijman R, Nathoe HM, Borst C, Jansen EW, et al. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA. 2007;297:701&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">17312289</ArticleId></ArticleIdList></Reference><Reference><Citation>Eggermont LHP, de Boer K, Muller M, Jaschke AC, Kamp O, Scherder EJA. Cardiac disease and cognitive impairment:a systematic review. Heart. 2012;98:1334&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">22689718</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanning JP, Wong AA, Fraser JF. The epidemiology of silent brain infarction:a systematic review of population-based cohorts. BMC Med. 2014;12:119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4226994</ArticleId><ArticleId IdType="pubmed">25012298</ArticleId></ArticleIdList></Reference><Reference><Citation>Fanning JP, Wesley AJ, Walters DL, Eeles EM, Barnett AG, Platts DG, et al. Neurological injury in intermediate-risk transcatheter aortic valve implantation. J Am Heart Assoc. 2016;5:e004203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5210348</ArticleId><ArticleId IdType="pubmed">27849158</ArticleId></ArticleIdList></Reference><Reference><Citation>Song R, Xu H, Dintica CS, Pan KY, Qi X, Buchman AS, et al. Associations between cardiovascular risk, structural brain changes, and cognitive decline. J Am Coll Cardiol. 2020;75:2525&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10061875</ArticleId><ArticleId IdType="pubmed">32439001</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito A, Goto T, Maekawa K, Baba T, Mishima Y, Ushijima K. Postoperative neurological complications and risk factors for pre-existing silent brain infarction in elderly patients undergoing coronary artery bypass grafting. J Anesth. 2012;26:405&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">22278375</ArticleId></ArticleIdList></Reference><Reference><Citation>Kline RP, Pirraglia E, Cheng H, De Santi S, Li Y, Haile M, et al. Alzheimer's Disease Neuroimaging Initiative. Surgery and brain atrophy in cognitively normal elderly subjects and subjects diagnosed with mild cognitive impairment. Anesthesiology. 2012;116:603&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3418798</ArticleId><ArticleId IdType="pubmed">22293721</ArticleId></ArticleIdList></Reference><Reference><Citation>Bown CW, Do R, Khan OA, Liu D, Cambronero FE, Moore EE, et al. Lower cardiac output relates to longitudinal cognitive decline in aging adults. Front Psychol. 2020;11:569355.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7680861</ArticleId><ArticleId IdType="pubmed">33240156</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall RS, Festa JR, Cheung YK, Pavol MA, Derdeyn CP, Clarke WR, et al. Randomized Evaluation of Carotid Occlusion and Neurocognition (RECON) trial:main results. Neurology. 2014;82:744&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3945653</ArticleId><ArticleId IdType="pubmed">24477109</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37482119</PMID><DateCompleted><Year>2023</Year><Month>12</Month><Day>26</Day></DateCompleted><DateRevised><Year>2024</Year><Month>11</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2174-2030</ISSN><JournalIssue CitedMedium="Internet"><Volume>43</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology</Title><ISOAbbreviation>Rev Port Cardiol</ISOAbbreviation></Journal><ArticleTitle>Interventional cardiology in cancer patients: A position paper from the Portuguese Cardiovascular Intervention Association and the Portuguese Cardio-Oncology Study Group of the Portuguese Society of Cardiology.</ArticleTitle><Pagination><StartPage>35</StartPage><EndPage>48</EndPage><MedlinePgn>35-48</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.repc.2023.04.013</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0870-2551(23)00382-7</ELocationID><Abstract><AbstractText>The field of Cardio-Oncology has grown significantly, especially during the last decade. While awareness of cardiotoxicity due to cancer disease and/or therapies has greatly increased, much of the attention has focused on myocardial systolic disfunction and heart failure. However, coronary and structural heart disease are also a common issue in cancer patients and encompass the full spectrum of cardiotoxicity. While invasive percutaneous or surgical intervention, either is often needed or considered in cancer patients, limited evidence or guidelines are available for dealing with coronary or structural heart disease. The Society for Cardiovascular Angiography and Interventions consensus document published in 2016 is the most comprehensive document regarding this particular issue, but relevant evidence has emerged since, which render some of its considerations outdated. In addition to that, the recent 2022 ESC Guidelines on Cardio-Oncology only briefly discuss this topic. As a result, the Portuguese Association of Cardiovascular Intervention and the Cardio-Oncology Study Group of the Portuguese Society of Cardiology have partnered to produce a position paper to address the issue of cardiac intervention in cancer patients, focusing on percutaneous techniques. A brief review of available evidence is provided, followed by practical considerations. These are based both on the literature as well as accumulated experience with these types of patients, as the authors are either interventional cardiologists, cardiologists with experience in the field of Cardio-Oncology, or both.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier Espa&#xf1;a, S.L.U. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Nobre Menezes</LastName><ForeName>Miguel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unidade de Cardiologia de Interven&#xe7;&#xe3;o Joaquim Oliveira, Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, Hospital de Santa Maria, Portugal; Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Centro Acad&#xe9;mico de Medicina de Lisboa, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal; Grupo de Estudos de Cardio-Oncologia, Sociedade Portuguesa de Cardiologia, Portugal; Associa&#xe7;&#xe3;o Portuguesa de Interven&#xe7;&#xe3;o Cardiovascular, Sociedade Portuguesa de Cardiologia, Portugal. Electronic address: mnmenezes.gm@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tavares da Silva</LastName><ForeName>Marta</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grupo de Estudos de Cardio-Oncologia, Sociedade Portuguesa de Cardiologia, Portugal; Associa&#xe7;&#xe3;o Portuguesa de Interven&#xe7;&#xe3;o Cardiovascular, Sociedade Portuguesa de Cardiologia, Portugal; Servi&#xe7;o de Cardiologia, Centro Hospitalar e Universit&#xe1;rio de S&#xe3;o Jo&#xe3;o, Porto, Portugal; UnIC@RISE, Departamento de Cirurgia e Fisiologia, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Magalh&#xe3;es</LastName><ForeName>Andreia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Centro Acad&#xe9;mico de Medicina de Lisboa, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal; Grupo de Estudos de Cardio-Oncologia, Sociedade Portuguesa de Cardiologia, Portugal; Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, Hospital de Santa Maria, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melica</LastName><ForeName>Bruno</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o Portuguesa de Interven&#xe7;&#xe3;o Cardiovascular, Sociedade Portuguesa de Cardiologia, Portugal; Cardiology Department, Vila Nova de Gaia Hospital, Vila Nova de Gaia, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toste</LastName><ForeName>J&#xfa;lia Cristina</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Grupo de Estudos de Cardio-Oncologia, Sociedade Portuguesa de Cardiologia, Portugal; Department of Cardiology, Hospital da Luz, Lisbon, Portugal; NOVA Medical School, Lisbon, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cal&#xe9;</LastName><ForeName>Rita</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o Portuguesa de Interven&#xe7;&#xe3;o Cardiovascular, Sociedade Portuguesa de Cardiologia, Portugal; Cardiology Department, Hospital Garcia de Orta EPE, Almada, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Almeida</LastName><ForeName>Manuel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o Portuguesa de Interven&#xe7;&#xe3;o Cardiovascular, Sociedade Portuguesa de Cardiologia, Portugal; Unidade de Interven&#xe7;&#xe3;o Cardiovascular I Centro Hospitalar de Lisboa Ocidental e CHRC, NOVA Medical School|Faculdade de Ci&#xea;ncias M&#xe9;dicas, NMS|FCM, Universidade Nova de Lisboa, Lisboa, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fiuza</LastName><ForeName>Manuela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Cardiovascular da Universidade de Lisboa (CCUL@RISE), Centro Acad&#xe9;mico de Medicina de Lisboa, Faculdade de Medicina da Universidade de Lisboa, Lisboa, Portugal; Grupo de Estudos de Cardio-Oncologia, Sociedade Portuguesa de Cardiologia, Portugal; Servi&#xe7;o de Cardiologia, Departamento de Cora&#xe7;&#xe3;o e Vasos, Centro Hospitalar Universit&#xe1;rio Lisboa Norte, Hospital de Santa Maria, Portugal.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Infante de Oliveira</LastName><ForeName>Eduardo</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Associa&#xe7;&#xe3;o Portuguesa de Interven&#xe7;&#xe3;o Cardiovascular, Sociedade Portuguesa de Cardiologia, Portugal; Hospital Lus&#xed;adas Lisboa, Portugal; Hospital Santa Cruz, Centro Hospitalar de Lisboa Ocidental, Carnaxide, Portugal.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><Language>por</Language><PublicationTypeList><PublicationType UI="D017065">Practice Guideline</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>22</Day></ArticleDate></Article><MedlineJournalInfo><Country>Portugal</Country><MedlineTA>Rev Port Cardiol</MedlineTA><NlmUniqueID>8710716</NlmUniqueID><ISSNLinking>0870-2551</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000097562" MajorTopicYN="N">Cardio-Oncology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011174" MajorTopicYN="N" Type="Geographic">Portugal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D066126" MajorTopicYN="N">Cardiotoxicity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006331" MajorTopicYN="Y">Heart Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002309" MajorTopicYN="Y">Cardiology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D062645" MajorTopicYN="Y">Percutaneous Coronary Intervention</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="Y">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acute coronary syndrome</Keyword><Keyword MajorTopicYN="N">Aortic stenosis</Keyword><Keyword MajorTopicYN="N">Cardio-Oncologia</Keyword><Keyword MajorTopicYN="N">Cardio-Oncology</Keyword><Keyword MajorTopicYN="N">Chronic coronary syndrome</Keyword><Keyword MajorTopicYN="N">Comissurotomia mitral percut&#xe2;nea</Keyword><Keyword MajorTopicYN="N">Coronary artery disease</Keyword><Keyword MajorTopicYN="N">Doen&#xe7;a card&#xed;aca estrutural</Keyword><Keyword MajorTopicYN="N">Doen&#xe7;a coron&#xe1;ria</Keyword><Keyword MajorTopicYN="N">Doen&#xe7;a valvular</Keyword><Keyword MajorTopicYN="N">Encerramento percut&#xe2;neo de ap&#xea;ndice auricular esquerdo</Keyword><Keyword MajorTopicYN="N">Estenose a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Implanta&#xe7;&#xe3;o percut&#xe2;nea de v&#xe1;lvula a&#xf3;rtica</Keyword><Keyword MajorTopicYN="N">Interven&#xe7;&#xe3;o coron&#xe1;ria percut&#xe2;nea</Keyword><Keyword MajorTopicYN="N">Left atrial appendage occlusion</Keyword><Keyword MajorTopicYN="N">Mitral regurgitation</Keyword><Keyword MajorTopicYN="N">Percutaneous coronary intervention</Keyword><Keyword MajorTopicYN="N">Percutaneous mitral valve commissurotomy</Keyword><Keyword MajorTopicYN="N">Regurgita&#xe7;&#xe3;o mitral</Keyword><Keyword MajorTopicYN="N">Structural heart disease</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome coron&#xe1;ria aguda</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome coron&#xe1;ria cr&#xf3;nica</Keyword><Keyword MajorTopicYN="N">Transcatheter aortic valve implantation</Keyword><Keyword MajorTopicYN="N">Valvular heart disease</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>4</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>12</Month><Day>26</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>24</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>23</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37482119</ArticleId><ArticleId IdType="doi">10.1016/j.repc.2023.04.013</ArticleId><ArticleId IdType="pii">S0870-2551(23)00382-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>